Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | MAPT | P10636 | 4/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | XBP1 | P17861 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | TYR | P14679 | 2/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10860893 | 0.82 | ALDH1A1 (0.73) | ALDH1A1MAPTLMNASMN1; SMN2HTT | |
| SCHEMBL10179968 | 0.81 | ALDH1A1 (0.47) | ALDH1A1MAPTLMNASMN1; SMN2HTT | |
| SCHEMBL27742835 | 0.79 | ALDH1A1 (0.42) | ALDH1A1MAPTLMNASMN1; SMN2HTT | |
| SCHEMBL10181499 | 0.77 | KAT6A (0.41) | ALDH1A1MAPTLMNASMN1; SMN2HTT | |
| SCHEMBL13542597 | 0.76 | TLR9 (0.45) | ALDH1A1MAPTLMNAMAPK1NPC1 | |
| SCHEMBL6038801 | 0.76 | ALDH1A1 (0.50) | ALDH1A1MAPTLMNASMN1; SMN2HTT | |
| SCHEMBL29618 | 0.76 | ALDH1A1 (0.56) | ALDH1A1MAPTLMNASMN1; SMN2TSHR | |
| SCHEMBL4300190 | 0.76 | ALDH1A1 (0.59) | ALDH1A1MAPTLMNASMN1; SMN2HTT | |
| SCHEMBL1374724 | 0.76 | TSHR (0.59) | ALDH1A1MAPTLMNASMN1; SMN2HTT | |
| SCHEMBL2889896 | 0.76 | TLR9 (0.67) | ALDH1A1MAPTLMNASMN1; SMN2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9102699-B2 | Sialic acid derivatives | LIPOXEN TECHNOLOGIES LIMITED (GB) | 2015-08-11 | — | — | US | disclosed |
| US-20140309409-A1 | Sialic Acid Derivatives | LIPOXEN TECHNOLOGIES LIMITED (GB) | 2014-10-16 | — | — | US | disclosed |
| US-8765936-B2 | Sialic acid derivatives | LIPOXEN TECHNOLOGIES LIMITED (GB) | 2014-07-01 | — | — | US | disclosed |
| US-20130244122-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTE BATTERY EMPLOYING THE SAME | ONUKI MASAMICHI (JP) | 2013-09-19 | — | — | US | disclosed |
| US-20130096294-A1 | SIALIC ACID DERIVATIVES | LIPOXEN TECHNOLOGIES LIMITED (GB) | 2013-04-18 | — | — | US | disclosed |
| US-20120219866-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS-ELECTROLYTE BATTERY EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2012-08-30 | — | — | US | disclosed |
| EP-2475041-A1 | NON-AQUEOUS ELECTROLYTIC SOLUTION, AND NON-AQUEOUS ELECTROLYTE BATTERY COMPRISING SAME | Mitsubishi Chemical Corporation (JP) | 2012-07-11 | — | — | EP | disclosed |
| US-4260552-A | INSECTICIDES, HERBICIDES | UNIROYAL, INC. (US) | 1981-04-07 | — | — | US | disclosed |
| US-4160846-A | Method for controlling insects with tetrasubstituted organotin compounds | UNIROYAL, INC. (US) | 1979-07-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140309409-A1 | Sialic Acid Derivatives | NEU2, NEU4, NEU1 | ALDH1A1 490/4885MAPT 3381/4885LMNA 1911/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.